RxDoctor Payments Data

Allison Slice

Family · Florence, SCNPI 1801869797

Payments from drug & device makers

$4,743in general payments, 2019–2025

Across 302 payments — averaging $15.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$573
  • AstraZeneca$303
  • Lilly USA, LLC$274
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$266
  • Pfizer$228
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$4,743100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,743 in reported general payments places this provider in the 90th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$115,774
Medicare patients
361
Services billed
1,914

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide66$77,086
JanuviaSitagliptin Phosphate90$74,152
JardianceEmpagliflozin59$68,670
OzempicSemaglutide44$51,443
EliquisApixaban34$35,609
LinzessLinaclotide39$33,460
TrulicityDulaglutide28$33,275
FarxigaDapagliflozin Propanediol30$29,746
XareltoRivaroxaban19$20,220
JanumetSitagliptin Phos/Metformin Hcl16$20,145
Tresiba Flextouch U-100Insulin Degludec16$17,754
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$16,624
Lantus SolostarInsulin Glargine,hum.Rec.Anlog57$6,342
NexletolBempedoic Acid12$4,704
Rosuvastatin Calcium153$2,974

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$274$110,36194 claims
Boehringer IngelheimJardiance$47$68,67059 claims
Novo NordiskOzempic$573$51,44344 claims
PfizerEliquis$228$35,60934 claims
AbbVieLinzess, Synthroid$1,348$35,53464 claims
AstraZenecaFarxiga$303$29,74630 claims
GSKTrelegy Ellipta$68$16,62424 claims
Esperion Therapeutics, Inc.Nexletol$27$4,70412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,248 family providers in South Carolina.

Other family in Florence

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →